Earnings History Data for Kenvue Inc. (KVUE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kenvue Inc.

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2025	PM	KVUE	Kenvue Inc.	27,328	N/A	0.27	0.00	Kenvue Non-GAAP EPS of $0.28, revenue of $3.76B [11/3/2025 3:17 PM]	16.19	1.82 (12.67%)	17.15	2.78 (19.35%)	14.02 - 25.17	162,645,550	31,400,000	23,104,818
M&A Snapshot: Kimberly-Clark to buy Kenvue in $48.7B cash-and-stock deal [11/3/2025 8:21 AM] Kimberly-Clark to acquire Kenvue in deal valuing Tylenol maker at $48.7 billion [11/3/2025 7:04 AM] Kenvue surges, Kimberly-Clark declines following acquisition announcement [11/3/2025 12:07 PM] Kenvue could see interest from other suitors - analyst [11/3/2025 3:20 PM] Kenvue Non-GAAP EPS of $0.28, revenue of $3.76B [11/3/2025 3:17 PM] Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger [2025-11-03 02:23PM] Kimberly-Clark bets $40 billion on Kenvue despite Tylenol controversy [2025-11-03 02:13PM] Squawk Pod: Big Tech's big challenges & Transportation Sec. Sean Duffy - 11/03/25 Audio Only [2025-11-03 02:05PM] Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal. [2025-11-03 01:56PM] Stocks to Watch Monday: Kenvue, IREN, Berkshire, Amazon [2025-11-03 12:58PM] Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue [2025-11-03 12:45PM] Drug giant hit by Trump autism claims bought for record $49bn [2025-11-03 12:40PM] Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More [2025-11-03 12:29PM] Kimberly-Clark to Buy Kenvue in $48.7 Billion Deal [2025-11-03 11:58AM] Tylenols parent company will combine with the maker of Huggies in a $48.7 billion mega-deal [2025-11-03 11:47AM] Tylenol trust crisis: Trump, RFK Jr. and Texas lawsuits slam Kenvue [2025-11-03 11:33AM] Stock Market Today: Stocks Rise To Start Week As Tylenol Maker Kenvue Inks $48.7 Billion Megadeal [2025-11-03 11:26AM] S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue soars after buyout [2025-11-03 11:25AM] Kimberly-Clark Stock Heads for Biggest One-Day Drop Since Black Monday [2025-11-03 11:15AM] Kimberly-Clark to buy maker of Tylenol in $48.7 billion cash-and-stock deal [2025-11-03 10:59AM] Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know [2025-11-03 10:54AM] Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal [2025-11-03 10:34AM] Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day. [2025-11-03 10:33AM] Tylenol maker Kenvue leads S&P 500, boosted by $48.7 billion Kimberly-Clark deal [2025-11-03 10:18AM] Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant [2025-11-03 10:05AM] These Stocks Are Moving the Most Today: Kenvue, Kimberly-Clark, Amazon, Berkshire Hathaway, Palantir, IREN, Cipher Mining, and More [2025-11-03 09:55AM] Stock market today: S&P 500, Nasdaq jump to kick off November as Amazon, Nvidia lead way [2025-11-03 09:37AM] Stock market today: Dow slips, Nasdaq pops as Amazon's OpenAI deal boosts AI bets [2025-11-03 09:37AM] Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking. [2025-11-03 09:35AM] Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal [2025-11-03 09:34AM] Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal [2025-11-03 09:33AM] Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger [2025-11-03 09:16AM] Berkshire earnings, Kimberly-Clark's deal to buy Tylonel maker [2025-11-03 09:15AM] Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal [2025-11-03 09:05AM] Kimberly-Clark to Buy Tylenol Maker Kenvue in $48.7B Deal. Kimberly-Clark Stock Tanks. [2025-11-03 08:47AM] Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal [2025-11-03 08:43AM] Tylenol Maker Scooped Up In $49 Billion Deal [2025-11-03 08:41AM] Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion [2025-11-03 08:27AM] Kimberly-Clark is buying Tylenol maker Kenvue for more than $48 billion [2025-11-03 08:21AM] Kimberly-Clark buys Tylenol maker Kenvue for more than $48 billion [2025-11-03 08:19AM] 5 Things to Know Before the Stock Market Opens [2025-11-03 07:42AM] It's been a disappointing ride for many Kenvue shareholders [2025-11-03 07:38AM] Kenvue jumps 22% on $48.7 billion Kimberly-Clark merger deal [2025-11-03 07:22AM] Kimberly-Clark to Buy Tylenol Maker Kenvue for More Than $40 Billion [2025-11-03 07:22AM] Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal, creating a massive consumer health goods company [2025-11-03 07:18AM] Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion [2025-11-03 06:50AM] Kimberly-Clark to Acquire Kenvue [2025-11-03 06:47AM] Kimberly-Clark to Buy Tylenol Maker Kenvue [2025-11-03 06:44AM] Kenvue: Q3 Earnings Snapshot [2025-11-03 06:37AM] Kenvue Reports Third Quarter 2025 Results [2025-11-03 06:30AM] Stock Market Today: Dow, S&P 500 and Nasdaq set to rise as Buffett's Berkshire Hathaway builds cash, more earnings await [2025-11-03 04:31AM]
07-08-2025	PM	KVUE	Kenvue Inc.	41,550	0.29	0.28	0.32	Kenvue Non-GAAP EPS of $0.29 beats by $0.01, revenue of $3.84B misses by $10M [8/7/2025 6:47 AM]	21.79	0.34 (1.61%)	22.00	0.56 (2.61%)	19.75 - 25.17	25,283,703	19,570,000	77,334
Kenvue Q2 2025 Earnings Preview [8/6/2025 10:44 AM] Kenvue Non-GAAP EPS of $0.29 beats by $0.01, revenue of $3.84B misses by $10M [8/7/2025 6:47 AM] Kenvue outlines low single-digit organic sales decline for 2025 as leadership transitions and strategic review progress [8/7/2025 12:29 PM]
08-05-2025	PM	KVUE	Kenvue Inc.	45,050	0.24	0.22	0.28	Kenvue Non-GAAP EPS of $0.24 beats by $0.01, revenue of $3.74B beats by $60M [5/8/2025 6:51 AM]	24.04	0.93 (4.02%)	24.20	1.09 (4.72%)	17.67 - 25.17	27,707,693	18,310,000	467,512
Kenvue Q1 2025 Earnings Preview [5/7/2025 12:53 PM] Kenvue Non-GAAP EPS of $0.24 beats by $0.01, revenue of $3.74B beats by $60M [5/8/2025 6:51 AM] Kenvue taps Amit Banati as CFO [5/8/2025 7:07 AM] Kenvue updates 2025 EPS guidance amid strategic pricing and innovation plans [5/8/2025 12:44 PM] Kenvue Reports First Quarter 2025 Results [2025-05-08 06:50AM] Kenvue Announces Chief Financial Officer Transition [2025-05-08 06:45AM] Here are the major earnings before the open tomorrow [May-07-25 06:00PM] Gordon Haskett says California Tylenol case dismissal significant Kenvue win [May-07-25 12:11PM] Edgewell Personal Care (EPC) Q2 Earnings and Revenues Lag Estimates [May-07-25 07:10AM]
06-02-2025	PM	KVUE	Kenvue Inc.	39,900	0.26	0.26	0.31	Kenvue misses Q4 revenue estimates [2/6/2025 6:49 AM]	19.79	-0.95 (-4.58%)	20.73	-0.01 (-0.05%)	17.67 - 24.46	22,364,824	13,500,000	127,752
Kenvue Q4 2024 Earnings Preview [2/5/2025 12:15 PM] Kenvue confirms activist Starboard nominations for board [2/5/2025 11:11 AM] Kenvue misses Q4 revenue estimates [2/6/2025 6:49 AM] Kenvue targets 2%-4% organic sales growth in 2025 with expanded innovations [2/6/2025 2:41 PM] Kenvue Reports Full Year and Fourth Quarter 2024 Results [2025-02-06 06:45AM] Is Kenvue Inc. (KVUE) One of the Best Beauty Stocks to Buy According to Hedge Funds? [Feb-05-25 10:54AM] Kenvue Highlights Commitment to Shareholder Value [Feb-05-25 10:39AM] Starboard Launches Proxy Fight at Kenvue [Feb-05-25 09:06AM]
07-11-2024	PM	KVUE	Kenvue Inc.	44,490	0.28	0.27	0.31	Kenvue Non-GAAP EPS of $0.28 beats by $0.01, revenue of $3.9B misses by $20M [11/7/2024 6:48 AM]	22.97	0.47 (2.09%)	22.31	-0.19 (-0.84%)	17.67 - 23.57	23,149,162	16,140,000	549,323
Kenvue Q3 2024 Earnings Preview [11/6/2024 12:14 PM] Kenvue Non-GAAP EPS of $0.28 beats by $0.01, revenue of $3.9B misses by $20M [11/7/2024 6:48 AM] FDA proposes removing oral decongestant phenylephrine from OTC meds [11/7/2024 2:44 PM] Kenvue Reports Third Quarter 2024 Results [2024-11-07 06:45AM]
06-08-2024	PM	KVUE	Kenvue Inc.	35,670	0.32	0.28	0.32	Kenvue beats top-line and bottom-line estimates; reaffirms FY24 outlook [8/6/2024 6:47 AM]	20.86	2.66 (14.65%)	20.08	1.89 (10.39%)	17.67 - 24.10	38,903,561	16,370,000	1,022,279
Kenvue Q2 2024 Earnings Preview [8/5/2024 11:46 AM] Kenvue beats top-line and bottom-line estimates; reaffirms FY24 outlook [8/6/2024 6:47 AM] Kenvue Q2 profits improve on efforts to create more agile organization [8/6/2024 8:23 AM]
07-05-2024	PM	KVUE	Kenvue Inc.	36,608	0.28	0.25	0.00	Kenvue Non-GAAP EPS of $0.28 beats by $0.03, revenue of $3.9B beats by $110M [5/7/2024 6:47 AM]	20.22	1.34 (7.10%)	19.45	0.57 (3.02%)	17.82 - 27.80	26,046,799	19,030,000	86,487
Kenvue Non-GAAP EPS of $0.28 beats by $0.03, revenue of $3.9B beats by $110M [5/7/2024 6:47 AM] Kenvue to slash global workforce by 4% in cost savings move [5/7/2024 12:51 PM]
08-02-2024	PM	KVUE	Kenvue Inc.	39,450	0.31	0.28	0.00	Kenvue Non-GAAP EPS of $1.29 beats by $1.01, revenue of $3.7B misses by $90M [2/8/2024 7:02 AM]	19.34	-1.18 (-5.77%)	19.89	-0.63 (-3.07%)	17.82 - 27.80	39,731,948	13,750,000	227,116
Kenvue Non-GAAP EPS of $1.29 beats by $1.01, revenue of $3.7B misses by $90M [2/8/2024 7:02 AM]
26-10-2023	PM	KVUE	Kenvue Inc.	38,260	0.31	0.30	0.00	Kenvue Non-GAAP EPS of $0.31 in-line, revenue of $3.92B beats by $10M [10/26/2023 6:41 AM]	18.70	-1.04 (-5.25%)	18.65	-1.08 (-5.47%)	18.50 - 27.80	49,221,681	19,220,000	4,066,720
Kenvue Non-GAAP EPS of $0.31 in-line, revenue of $3.92B beats by $10M [10/26/2023 6:41 AM]
20-07-2023	PM	KVUE	Kenvue Inc.	47,660	0.32	0.29	0.00	Kenvue beats Q2 top and bottom line estimates; initiates FY23 outlook [7/20/2023 6:29 AM]	24.50	-0.50 (-2.00%)	24.00	-1.00 (-4.00%)	22.49 - 27.80	35,948,291	2,560,000	83,671
Kenvue beats Q2 top and bottom line estimates; initiates FY23 outlook [7/20/2023 6:29 AM] Kenvue initiates quarterly cash dividend of $0.20 [7/20/2023 7:54 AM] J&J could reportedly launch Kenvue exchange offer in "coming days" [7/20/2023 11:40 AM]